The cancer therapeutics market size is expected to reach US$ 5,31,538.02 million by 2031 from US$ 2,30,423.56 million in 2024. The market is estimated to record a CAGR of 12.8% from 2025 to 2031.

 

Executive Summary and Global Market Analysis

The global cancer therapeutics market is experiencing significant growth, primarily fueled by the increasing prevalence of breast and lung cancer and substantial investments in oncology research. Cancer therapeutics encompass a broad range of treatments designed to manage or cure cancer. Common treatment approaches include chemotherapy, radiation, immunotherapy, targeted therapy, hormone therapy, surgical interventions, and stem cell therapy. All these strategies aim to eliminate or control cancer cells, alleviate symptoms, and enhance patient survival. Often, treatment involves a combination of therapies, customized to the specific cancer type and stage, as well as the patient's overall health, to maximize effectiveness.

Download our Sample PDF Report

@ https://www.businessmarketinsights.com/sample/BMIRE00031299

 

Cancer Therapeutics Market Segmentation Analysis

The cancer therapeutics market is segmented by therapy type, indication, and distribution channel.

 

By therapy type, the market is categorized into chemotherapy, targeted therapy, radiation therapy, hormone therapy, and other forms of therapy. Chemotherapy held the largest market share in 2024.

In terms of indications, the market includes blood cancer, lung cancer, breast cancer, colorectal cancer, prostate cancer, stomach cancer, cervical cancer, liver and intrahepatic bile duct cancer, thyroid cancer, and other indications. Lung cancer accounted for the largest market share in 2024.

By distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online stores. Hospital pharmacies maintained the largest market share in 2024.

Cancer Therapeutics Market Drivers and Opportunities

According to the World Health Organization, various types of cancer are responsible for approximately 1 in every 6 deaths globally. In 2022, there were an estimated 20 million new cancer cases and 9.7 million deaths associated with the disease. This burden is projected to increase by roughly 77% by 2050, which will further strain healthcare systems and communities. The American Cancer Society reports that 5–10% of all cancers are inherited. Numerous genes associated with cancer predisposition have been identified; for example, mutations in inherited cancer predisposition genes like BRCA1 and BRCA2 increase the risk of developing various cancers, including breast, ovarian, and prostate cancer. Breast cancer is considered the most prevalent cancer among women worldwide, with a continuously rising incidence attributed to risk factors such as environmental impact, genetic susceptibility, hormone imbalances, and lifestyle changes. Additionally, breast cancer is among the most prevalent cancers in the U.S.

 

Cancer Therapeutics Market Size and Share Analysis

By therapy type, the cancer therapeutics market is segmented into chemotherapy, targeted therapy, radiation therapy, hormone therapy, and other therapy types. The chemotherapy segment dominated the market in 2024. Chemotherapy drugs, which circulate throughout the body, disrupt the growth of cancer cells through their cytotoxic ability, thereby stopping or slowing down cell growth. As per National Institutes of Health estimates, approximately 650,000 cancer patients in the US receive chemotherapy each year in oncology clinics.

 

In terms of indications, the market is segmented into blood cancer, lung cancer, breast cancer, colorectum cancer, prostate cancer, stomach cancer, cervical cancer, liver and intrahepatic bile duct cancer, thyroid cancer, and other indications. The lung cancer segment held the largest share of the market in 2024.

 

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications